SBI Holdings Dangles XRP for a Plain Bond Sale in Japan
SBI Holdings is issuing a ¥10 billion three-year retail bond with an XRP perk tied to SBI VC Trade accounts, aiming t...
Budgeting Tools For Financial Planning
Budgeting tools can simplify your financial planning. Learn about effective resources to help you manage your budget and achieve your financial goals.
10,146 articles
Should Cryptocurrency While It's Under $1.50? XRP Guide
XRP has cooled off near $1.50 after a sharp drop. Before you buy the dip, learn what drives XRP's price, how Ripple's...
Intuitive Machines Bought $800M: Markets React with Caution
Intuitive Machines announced an $800 million acquisition that pivots the company from lunar landers to a full space p...
Trump’s 401(k) Match Collides with Real-World Pain
A proposed federal 401(k) match faces a reality gap: while it aims to help workers without employer plans, millions a...
Down 70%, Should Rigetti Buy the Dip Right Now?
Rigetti Computing has dropped about 70% from its 52-week high. This article breaks down whether the dip offers real u...
Fidelity CEO’s Surprise Record as Crypto Visionary
Fidelity Investments’ leadership, led by Abby Johnson, has quietly built a decades-long crypto program that critics n...
Kevin Hassett Says Economists Should Be Disciplined
A New York Fed tariff study finds most costs fall on U.S. businesses and consumers, prompting Kevin Hassett to demand...
From Stellar Canton: Franklin Tokenization Strategy
Franklin Templeton’s tokenization journey marks a turning point for traditional asset managers. This article breaks d...
Murphy Sells $344k Worth: SVP Insider Move Signals Investor Attention
A Murphy USA senior executive recently sold shares in an open-market move valued at roughly $344,000. This article br...
Berkshire’s Greg Abel Admits He Faces a Hard Act to Follow
In his first shareholder letter, Berkshire Hathaway’s new leader pledges continuity, a robust balance sheet, and read...
Xeris Biopharma (XERS) 2025 Outlook: Earnings & Pipeline
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Is Crispr Therapeutics Stock Risky Right Now? A Practical Guide for Investors
Biotech stocks can swing on clinical data and regulatory news. This guide digs into whether crispr therapeutics stock...
Popular Topics
Investment Strategies In Energy Sector
Smart Money Moves For Everyday Life
Investment Strategies
Ai Healthcare News
Budget
Credit Card Bonus Points Best
How To Plan For Retirement In Your 40s
Top Cryptocurrencies For Beginners
Factors Affecting Credit Card Rewards Accumulation
Which Cash Back Credit Card Should I Get
Cash Back Credit Card Payout Process
Free Courses On Financial Planning For Beginners
How To Take Advantage Of Catch Up Contributions At 50
Additional Income Ideas For Debt Repayment
Effective Budgeting Strategies To Save Money